NASDAQ:ARGX - argenx SE
$118.30
 $3.30
+2.87%
4:00PM EDT
2019-04-18
argenx SE, formerly arGEN X BV is the Netherlands-based biopharmaceutical company. It creates and develops a pipeline of differentiated antibody therapeutics using its discovery platform, Simple Antibody, which exploits characteristics of the llama immune system. The Company develops a pipeline of antibody therapeutics focused on cancer and autoimmune indications. It includes: ARGX-110, an antibody for heme malignancies and solid tumors, which modulates functions of tumor such as cell proliferation and survival; ARGX-111, an antagonist of c-Met, a receptor tyrosine kinase involved in cell proliferation, angiogenesis and metastasis in multiple solid tumors; ARGX-112, an antigen which targets atopic dermatitis by neutralization of IL-20 and IL-22 (interleukin) mediated signaling through blockade of their common receptor, among others. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  ARGX     avg for
industry  
  avg for
sector  
42 stocks weight:  216. 73   203. 85   241. 91  
42 stocks rank:  1. 14 K 1. 44 K 1. 05 K
# analyst opinions:  11. 00   14. 51   13. 97  
mean recommendation:  1. 70   2. 09   2. 01  

quick ratio:  14. 17   5. 27   1. 81  
current ratio:  14. 29   5. 62   2. 25  

target price low:  109. 95   84. 80   115. 21  
target price avg:  148. 30   111. 51   137. 51  
target price high:  160. 93   135. 81   157. 84  
1-yr high:  134. 59   114. 23   138. 78  
last close:  118. 30   87. 66   116. 69  
50-day avg:  125. 61   95. 54   123. 44  
200-day avg:  100. 18   94. 25   121. 11  
1-yr low:  63. 81   72. 78   98. 34  
volume:  287. 01 K 4. 11 M 8. 07 M
50-day avg volume:  166. 13 K 2. 76 M 5. 02 M
200-day avg volume:  208. 99 K 2. 92 M 4. 59 M

1-day return:  2. 87 % -0. 41 % 0. 07 %
this week return:  -6. 97 % -5. 74 % -4. 11 %
12-wk return:  11. 87 % 1. 61 % -0. 05 %
52-wk return:  31. 07 % 3. 12 % 8. 78 %

enterprise value (EV):  4. 49 B 48. 94 B 114. 64 B
market cap:  4. 50 B 43. 07 B 104. 73 B

shares outstanding:  32. 45 M 571. 70 M 1. 24 B
shares:  36. 63 M 571. 81 M 1. 23 B
shares short:  804. 77 K 10. 17 M 13. 00 M
shares short prior month:  697. 67 K 9. 54 M 17. 33 M
short ratio:  3. 59   5. 41   3. 28  

book value:  11. 95   12. 78   26. 92  
price/book:  9. 90   3. 06   -1. 74  
gross profits:  29. 23 M 8. 04 B 34. 86 B
operating margins:  0. 00 % -725. 35 % -89. 04 %
EBITDA margins:  -278. 39 % 10. 94 % 22. 51 %
profit margins:  -227. 98 % 7. 81 % 10. 57 %
gross margins:  -186. 03 % 37. 08 % 55. 70 %

1-yr max volatility:  20. 05 % --- ---
1-yr mean volatility:  0. 16 % 0. 03 % 0. 04 %

1-yr EPS:  -1. 73   2. 40   4. 10  
forward EPS:  -4. 27   3. 97   7. 13  
P/E:  -68. 58   13. 63   22. 72  
forward P/E:  -27. 70   -15. 95   13. 99  
PE/G:  1. 22   -1. 65   -1. 32  
growth:  -56. 10 % 127. 12 % 29. 61 %
earnings high:  -0. 76   1. 00   1. 66  
earnings avg:  -0. 89   0. 77   1. 53  
earnings low:  -1. -1   0. 50   1. 39  
revenue high:  26. 99 M 2. 68 B 10. 78 B
revenue avg:  13. 56 M 2. 59 B 10. 57 B
revenue low:  -0. 00   2. 49 B 10. 36 B
return on assets:  -10. 78 % -2. 75 % 4. 55 %
return on equity:  -15. 09 % -18. 45 % 5. 46 %
revenue growth:  -56. 10 % 92. 86 % 18. 96 %

beta (1yr vs S&P500):  1. 10   1. 25   0. 93  
sharpe (1yr):  0. 83   0. 37   0. 70  

held % insiders:  0. 00 % 6. 39 % 3. 38 %
held % institutions:  55. 81 % 78. 14 % 68. 52 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-04-21 : ARGX
.    + 9.152 =         9.152 :: INITIAL WEIGHT
.   + 21.166 =        30.317 :: inverse volume-to-price addition
.   + 45.316 =        75.633 :: spline projection addition
.    x 1.859 =       140.599 :: 13 weeks' performance factor
.    x 1.327 =       186.551 :: one-year gains+dividend factor
.    x 1.431 =       267.033 :: industry recommendation factor
.    x 2.834 =       756.785 :: symbol recommendation factor
.    x 0.999 =        755.97 :: return on assets factor
.    x 0.998 =       754.829 :: return on equity factor
.    x 0.994 =       750.594 :: revenue growth factor
.    x 2.541 =      1907.234 :: current ratio factor
.    x 1.037 =      1978.297 :: quick ratio factor
.    x 1.131 =       2236.92 :: short ratio factor
.    x 2.205 =      4932.414 :: price-to-book factor
.    x 1.219 =      6011.433 :: 5-day avg > 200-day avg
.    x 1.254 =      7537.785 :: 50-day avg > 200-day avg
.    x 1.021 =       7694.45 :: P/E weight
.    x 0.951 =      7317.612 :: PE/G factor
.    x 1.512 =     11063.086 :: beta factor
.     x 0.83 =      9185.561 :: sharpe factor
.    x 0.973 =      8941.523 :: target low factor
.    x 1.168 =     10442.446 :: target mean factor
.     x 1.06 =     11069.302 :: target high factor
.     x 1.31 =     14499.545 :: industry 2-weeks return factor
.    x 0.948 =     13742.149 :: "drift" penalty 3 days ago
.    x 0.923 =     12683.857 :: "drift" penalty 4 days ago
.    x 0.986 =     12508.461 :: "drift" penalty 5 days ago
.    x 0.979 =     12248.944 :: overall "drift" factor
.      x 0.8 =      9793.338 :: largest single-day jump factor
.     x 1.01 =      9891.116 :: mean volatility factor
.    x 1.098 =     10863.135 :: 42-day mean volatility factor
.      x 1.0 =     10861.372 :: factor hist industry gain for week 16
.   cubeRoot =        22.146 :: reduced to standardize
.   + 194.58 =       216.726 :: add/subtract for performance
.                    216.726 :: FINAL WEIGHT for NASDAQ:ARGX


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org